T 1395/21 (RSV/GSK) of 20.07.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T139521.20230720
- Date of decision
- 20 July 2023
- Case number
- T 1395/21
- Online on
- 25 July 2023
- Petition for review of
- -
- Application number
- 12702153.3
- IPC class
- A61K 39/155A61P 31/14
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- RSV immunization regimen
- Applicant name
- GlaxoSmithKline Biologicals SA
- Opponent name
- Pfizer Inc.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.